EBG is proud to present its outlook for transactions in the health care and life sciences industries in 2026. We expect the coming year, not unlike 2025, to present a dynamic investment environment that will require close monitoring of activities on the Hill, shifting priorities of the Administration, enforcement trends of regulatory authorities, and tension between federal and state legislators and the courts with respect to governing authority. These materials highlight our firm’s current perspective on driving influences on health care providers and life sciences businesses, respectively, to foster discussion as you consider potential opportunities in 2026. We look forward to working together this year to identify the avenues that lead to growth and innovation in health care and life sciences.